Last reviewed · How we verify
NCT01310985
A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer
trial testing Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®) in Colon Rectal Cancer Duke Stage Stageval in 15 participants. Completed in 1 August 2014.
1 August 2014
Quick facts
| Lead sponsor | King Faisal Specialist Hospital & Research Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 1 March 2008 |
| Primary completion | 1 August 2014 |
| Estimated completion | 1 August 2014 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®) — full drug profile →
Conditions studied
- Colon Rectal Cancer Duke Stage Stageval — all drugs for Colon Rectal Cancer Duke Stage Stageval →
Sponsor
King Faisal Specialist Hospital & Research Center
Who can join
Adults 14 to 85, any sex, with Colon Rectal Cancer Duke Stage Stageval. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Evaluate the safety of pre-operative concurrent chemotherapy with capacitabine (Xeloda), weekly cetuximab (Erbitux), and external beam radiation.
Time frame: For the duration of the experiment
Sponsor's own description
A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01310985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other King Faisal Specialist Hospital & Research Center trials
Trials by the same sponsor.
- NCT07429929 — Saudi Emergency Laparotomy Audit · not yet recruiting
- NCT07324174 — A Randomized Controlled Trial on the Effectiveness of Early Versus Conservative Rehabilitation Following Rotator Cuff Re · NA · not yet recruiting
- NCT07316777 — Saudi CABG Audit and Registry · not yet recruiting
- NCT07318571 — AI-Assisted Skin Assessment for Pressure Injury Prevention in Critical Care Nurses · NA · recruiting
- NCT07243041 — Code Status Discussions in Muslim ICU Patients: Insights Into Physician-Family Communication · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01310985 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Faisal Specialist Hospital & Research Center
- Last refreshed: 28 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01310985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing